
Association of Pre-PCI Blood Pressure and No-Reflow in Patients with Acute ST-Elevation Coronary Infarction
By: Xiaobo Li, Chen Yu, Li Lei, Xuewei Liu, Yejia Chen, Yutian Wang, ShiFeng Qiu and Jiancheng Xiu
References
- Prabhakaran D, Jeemon P, Roy A. Cardiovascular diseases in India: Current epidemiology and future directions. Circulation. 2016; 133: 1605–1620. DOI: 10.1161/circulationaha.114.008729
- Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39: 119–177. DOI: 10.1093/eurheartj/ehx393
- Fan F, Li Y, Zhang Y, Liu J, Hao Y, Smith SC
Jr. , Fonarow GC, Taubert KA, Ge J, Zhao D, Huo Y. CCC-ACS Investigators; Chest pain center accreditation is associated with improved in-hospital outcomes of acute myocardial infarction patients in China: Findings from the CCC-ACS Project. J Am Heart Assoc. 2019; 8:e002317 . DOI: 10.1161/jaha.118.002317 - Chandrashekhar Y, Alexander T, Mullasari A, Kumbhani DJ, Alam S, Alexanderson E, Bachani D, Wilhelmus Badenhorst JC, Baliga R, Bax JJ, et al. Resource and infrastructure-appropriate management of ST-segment elevation myocardial infarction in low- and middle-income countries. Circulation. 2020; 141: 2004–2025. DOI: 10.1161/circulationaha.119.041297
- Galiuto L, Rebuzzi AG, Crea F. The no-reflow phenomenon. JACC Cardiovasc Imaging. 2009; 2: 85–86. DOI: 10.1016/j.jcmg.2008.11.003
- Tasar O, Karabay AK, Oduncu V, Kirma C. Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Coron Artery Dis. 2019; 30: 270–276. DOI: 10.1097/mca.0000000000000726
- Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol. 2009; 54: 281–292. DOI: 10.1016/j.jacc.2009.03.054
- de Waha S, Patel MR, Granger CB, Ohman EM, Maehara A, Eitel I, Ben-Yehuda O, Jenkins P, Thiele H, Stone GW. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: An individual patient data pooled analysis from seven randomized trials. Eur Heart J. 2017; 38: 3502–3510. DOI: 10.1093/eurheartj/ehx414
- Resnic FS, Wainstein M, Lee MK, Behrendt D, Wainstein RV, Ohno-Machado L, Kirshenbaum JM, Rogers CD, Popma JJ, Piana R. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J. 2003; 145: 42–46. DOI: 10.1067/mhj.2003.36
- Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, Higashino Y, Fujii K, Minamino T. Clinical implications of the ‘no reflow’ phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996; 93: 223–228. DOI: 10.1161/01.cir.93.2.223
- Annibali G, Scrocca I, Aranzulla TC, Meliga E, Maiellaro F, Musumeci G. “No-Reflow” phenomenon: A contemporary review. J Clin Med. 2022; 11. DOI: 10.3390/jcm11082233
- Her AY, Ann SH, Singh GB, Kim YH, Koo BK, Shin ES. Prediction of coronary atherosclerotic ostial lesion with a damping of the pressure tracing during diagnostic coronary angiography. Yonsei Med J. 2016; 57: 58–63. DOI: 10.3349/ymj.2016.57.1.58
- Hoffman JI, Spaan JA. Pressure-flow relations in coronary circulation. Physiol Rev. 1990; 70: 331–390. DOI: 10.1152/physrev.1990.70.2.331
- Lefer AM, Tsao P, Aoki N, Palladino MA,
Jr . Mediation of cardioprotection by transforming growth factor-beta. Science. 1990; 249: 61–64. DOI: 10.1126/science.2164258 - Quillen JE, Sellke FW, Brooks LA, Harrison DG. Ischemia-reperfusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries. Circulation. 1990; 82: 586–594. DOI: 10.1161/01.cir.82.2.586
- Duncker DJ, Koller A, Merkus D, Canty JM
Jr . Regulation of coronary blood flow in health and ischemic heart disease. Prog Cardiovasc Dis. 2015; 57: 409–422. DOI: 10.1016/j.pcad.2014.12.002 - Chen Y, Wang C, Yang X, Wang L, Sun Z, Liu H, Chen L. Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention. Heart Vessels. 2012; 27: 243–249. DOI: 10.1007/s00380-011-0144-2
- Reffelmann T, Kloner RA. The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol. 2006; 101: 359–372. DOI: 10.1007/s00395-006-0615-2
- Krivokapich J, Czernin J, Schelbert HR. Dobutamine positron emission tomography: Absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease. J Am Coll Cardiol. 1996; 28: 565–572. DOI: 10.1016/0735-1097(96)00205-7
- Pantsios C, Kapelios C, Vakrou S, Diakos N, Pozios I, Kontogiannis C, Nanas J, Malliaras K. Effect of elevated reperfusion pressure on “no reflow” area and infarct size in a porcine model of ischemia-reperfusion. J Cardiovasc Pharmacol Ther. 2016; 21: 405–411. DOI: 10.1177/1074248415617850
- Hao Y, Liu J, Liu J, Smith SC
Jr. , Huo Y, Fonarow GC, Ma C, Ge J, Taubert KA, Morgan L, et al. Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome. Am Heart J. 2016; 179: 107–115. DOI: 10.1016/j.ahj.2016.06.005 - Ryan TJ, Bauman WB, Kennedy JW, Kereiakes DJ, King SB, McCallister BD, Smith SC
Jr. , Ullyot DJ. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 1993; 88: 2987–3007. DOI: 10.1161/01.cir.88.6.2987 - Gibson CM, Cannon CP, Daley WL, Dodge JT
Jr. , Alexander BJr. , Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, et al. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation. 1996; 93: 879–888. DOI: 10.1161/01.cir.93.5.879 - Li S, Schwartz JE, Shimbo D, Muntner P, Shikany JM, Booth JN
3rd , Allen NB, Jaeger BC, Bress AP, King JB, et al. Estimated prevalence of masked asleep hypertension in US adults. JAMA Cardiol. 2021; 6: 568–573. DOI: 10.1001/jamacardio.2020.5212 - Herrett E, Gadd S, Jackson R, Bhaskaran K, Williamson E, van Staa T, Sofat R, Timmis A, Smeeth L. Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: A retrospective cohort study. Lancet. 2019; 394: 663–671. DOI: 10.1016/s0140-6736(19)31359-5
- Bangalore S, Qin J, Sloan S, Murphy SA, Cannon CP. What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial. Circulation. 2010; 122: 2142–2151. DOI: 10.1161/circulationaha.109.905687
- Böhm M, Ferreira JP, Mahfoud F, Duarte K, Pitt B, Zannad F, Rossignol P. Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: Insights from the EPHESUS trial. Eur Heart J. 2020; 41: 1673–1683. DOI: 10.1093/eurheartj/ehaa132
- Ferreira JP, Duarte K, Pfeffer MA, McMurray JJV, Pitt B, Dickstein K, Zannad F, Rossignol P. Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: An analysis from the High-Risk Myocardial Infarction Database Initiative. Eur J Heart Fail. 2018; 20: 323–331. DOI: 10.1002/ejhf.1131
- Tang Y, Liu S, Shi Y, He T, Sun X, Wu M, Peng Z, Gui F, Yuan H, Lu Y, et al. Association of blood pressure in the first-week of hospitalization and long-term mortality in patients with acute left ventricular myocardial infarction. Int J Cardiol. 2022; 349: 18–26. DOI: 10.1016/j.ijcard.2021.11.045
- Srinivasan M, Rihal C, Holmes DR, Prasad A. Adjunctive thrombectomy and distal protection in primary percutaneous coronary intervention: impact on microvascular perfusion and outcomes. Circulation. 2009; 119: 1311–1319. DOI: 10.1161/circulationaha.108.831453
- Kloner RA, King KS, Harrington MG. No-reflow phenomenon in the heart and brain. Am J Physiol Heart Circ Physiol. 2018; 315: H550–H562. DOI: 10.1152/ajpheart.00183.2018
- Schwartz BG, Kloner RA. Coronary no reflow. J Mol Cell Cardiol. 2012; 52: 873–882. DOI: 10.1016/j.yjmcc.2011.06.009
- Heusch G, Kleinbongard P, Böse D, Levkau B, Haude M, Schulz R, Erbel R. Coronary microembolization: From bedside to bench and back to bedside. Circulation. 2009; 120: 1822–1836. DOI: 10.1161/circulationaha.109.888784
- Barrabés JA, Garcia-Dorado D, Mirabet M, Inserte J, Agulló L, Soriano B, Massaguer A, Padilla F, Lidón RM, Soler-Soler J. Antagonism of selectin function attenuates microvascular platelet deposition and platelet-mediated myocardial injury after transient ischemia. J Am Coll Cardiol. 2005; 45: 293–299. DOI: 10.1016/j.jacc.2004.09.068
- Ndrepepa G, Kastrati A. Coronary no-reflow after primary percutaneous coronary intervention-current knowledge on pathophysiology, diagnosis, clinical impact and therapy. J Clin Med. 2023; 12. DOI: 10.3390/jcm12175592
- Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019; 40: 87–165. DOI: 10.1093/eurheartj/ehy394
- Nanas JN, Tsolakis E, Terrovitis JV, Eleftheriou A, Drakos SG, Dalianis A, Charitos CE. Moderate systemic hypotension during reperfusion reduces the coronary blood flow and increases the size of myocardial infarction in pigs. Chest. 2004; 125: 1492–1499. DOI: 10.1378/chest.125.4.1492
- Hoffman JI, Buckberg GD. The myocardial oxygen supply: demand index revisited. J Am Heart Assoc. 2014; 3:
e000285 . DOI: 10.1161/jaha.113.000285 - Messerli FH, Mancia G, Conti CR, Hewkin AC, Kupfer S, Champion A, Kolloch R, Benetos A, Pepine CJ. Dogma disputed: Can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006; 144: 884–893. DOI: 10.7326/0003-4819-144-12-200606200-00005
- Weber T, Auer J, Eber B, O’Rourke MF. Diastolic blood pressure in coronary artery disease. Ann Intern Med. 2007; 146: 149. DOI: 10.7326/0003-4819-146-2-200701160-00016
- Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360: 1903–1913. DOI: 10.1016/s0140-6736(02)11911-8
- Herrington W, Staplin N, Judge PK, Mafham M, Emberson J, Haynes R, Wheeler DC, Walker R, Tomson C, Agodoa L, et al. Evidence for reverse causality in the association between blood pressure and cardiovascular risk in patients with chronic kidney disease. Hypertension. 2017; 69: 314–322. DOI: 10.1161/hypertensionaha.116.08386
- Park H, Hong YJ, Cho JY, Sim DS, Yoon HJ, Kim KH, Kim JH, Ahn Y, Jeong MH, Cho JG, et al. Blood pressure targets and clinical outcomes in patients with acute myocardial infarction. Korean Circ J. 2017; 47: 446–454. DOI: 10.4070/kcj.2017.0008
- Lip S, Tan LE, Jeemon P, McCallum L, Dominiczak AF, Padmanabhan S. Diastolic blood pressure J-curve phenomenon in a tertiary-care hypertension clinic. Hypertension. 2019; 74: 767–775. DOI: 10.1161/hypertensionaha.119.12787
- Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet. 2016; 387: 957–967. DOI: 10.1016/s0140-6736(15)01225-8
- Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JFE, Mancia G, Redon J, Schmieder RE, Sliwa K, et al. Achieved blood pressure and cardiovascular outcomes in high-risk patients: Results from ONTARGET and TRANSCEND trials. Lancet. 2017; 389: 2226–2237. DOI: 10.1016/s0140-6736(17)30754-7
- Huang L, Zhang J, Huang Q, Cui R, Chen J. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system. BMC Cardiovasc Disord. 2023; 23: 198. DOI: 10.1186/s12872-023-03214-x
- Knight SR, Ho A, Pius R, Buchan I, Carson G, Drake TM, Dunning J, Fairfield CJ, Gamble C, Green CA, et al. Risk stratification of patients admitted to hospital with Covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Development and validation of the 4C Mortality Score. BMJ. 2020; 370: m3339. DOI: 10.1136/bmj.m3339
- Antoni ML, Boden H, Delgado V, Boersma E, Fox K, Schalij MJ, Bax JJ. Relationship between discharge heart rate and mortality in patients after acute myocardial infarction treated with primary percutaneous coronary intervention. Eur Heart J. 2012; 33: 96–102. DOI: 10.1093/eurheartj/ehr293
DOI: https://doi.org/10.5334/gh.1309 | Journal eISSN: 2211-8179
Language: English
Submitted on: Dec 11, 2023
Accepted on: Feb 12, 2024
Published on: Mar 4, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2024 Xiaobo Li, Chen Yu, Li Lei, Xuewei Liu, Yejia Chen, Yutian Wang, ShiFeng Qiu, Jiancheng Xiu, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.